CX3CR1 and neoplasm: In an aggressive B16F10 murine melanoma model, IL-21 secretion stimulated by CD4+ TH cells drives CD8+ T cell differentiation towards CX3CR1+ cytotoxic effector phenotype and anti-tumor activity (84).